Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Doctors need to be better prepared to assess and treat obesity in patients.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

PCOS is a common condition in women that causes various symptoms and health issues, treatable with lifestyle changes and medication.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Differentiating PCOS from NCAH helps improve diagnosis and treatment.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.